LATISSE ® is a cosmetic dermatology treatment intended to help individuals grow longer eyelashes. Medical experts refer to hypotrichosis, where eyelash growth is inhibited, as a condition where LATISSE ® is a potential solution.
FDA Approval of LATISSE ®
Official press releases show that the U.S. Food and Drug Administration approved LATISSE ® for use in cosmetic dermatology in 2008. LATISSE ® is intended to provide length, thickness and darkness of eyelashes. Industry sources indicate that LATISSE ® is the first of its kind, a scientific treatment that produces longer lashes.
Along with a variety of clinical trials for safety, proponents of LATISSE ® point to another reason for its FDA approval and favorable safety profile. Bimatoprost, the active ingredient in LATISSE ® , was formerly used to treat medical conditions of the eye including ocular hypertension. Doctors who used bimatoprost as a treatment before the FDA approval of LATISSE ® could generally rely on their prior knowledge to help provide more detailed information to patients.
Safety with LATISSE ®
LATISSE ® is provided by prescription only. It is known to have several potential side effects. Those who want to use LATISSE ® as a treatment for longer lashes should consult with doctors about the safe application and use of LATISSE ® . for more specific information about LATISSE ® , readers can locate the website for the company Allergan, the makers of this innovative product.
